TY - JOUR
T1 - Effects of physical activities on dementia-related biomarkers
T2 - A systematic review of randomized controlled trials
AU - Moniruzzaman, Mohammad
AU - Kadota, Aya
AU - Akash, Maksudul Shadat
AU - Pruitt, Patrick J.
AU - Miura, Katsuyuki
AU - Albin, Roger
AU - Dodge, Hiroko H.
N1 - Funding Information:
We thank the Shiga University of Medical Science Leading Graduate Program for Reducing the Burden of Non-communicable Disease in the Asia Pacific Region; Shiga Medical Science Association for International Cooperation, Japan; and the Michigan Alzheimer’s Disease Center, University of Michigan (P30AG053760), USA, for their support in this review work. Funding sources: P30AG053760, P30AG008017.
Publisher Copyright:
© 2020 The Authors.
PY - 2020
Y1 - 2020
N2 - Introduction: Physical activities (PA) may lead to improved cognition in mild cognitive impairment (MCI), Alzheimer’s disease (AD), and dementia. Themechanismsmediating potential PA effects are unknown. Assessment of PA effects on relevant biomarkers may provide insights into mechanisms underlying potential PA effects on cognition. Methods:We systematically reviewed randomized controlled trials (RCTs) that studied PA effects on biomarkers in MCI, AD, and dementia populations. We examined whether biological mechanisms were hypothesized to explain associations among PA, biomarkers, and cognitive functions.We used the PubMed database and searched for RCTs with PA until October 31, 2019. Results: Of 653 studies examining changes in biomarkers in PA trials, 18 studies met inclusion criteria for the present review. Some studies found favorable effects of PA on neurotrophic and inflammatory biomarkers. AD pathological markers were rarely investigated, with inconclusive results. Most studies were relatively small in sample size, of limited duration, and not all studies compared the changes in biomarkers between the control and experimental groups. Discussion: There is only limited use of potentially informative biomarkers in PA trials for MCI, AD, and dementia.Most studies did not examine the role of biomarkers to study associations between PAand cognitive functions in their analyses. Several potential biomarkers remain uninvestigated. Careful use of biomarkers may clarify mechanisms underlying PA effects on cognition. Our review serves as a useful resource for developing future PA RCTs aimed at improving cognitive functions in MCI, AD, and dementias.
AB - Introduction: Physical activities (PA) may lead to improved cognition in mild cognitive impairment (MCI), Alzheimer’s disease (AD), and dementia. Themechanismsmediating potential PA effects are unknown. Assessment of PA effects on relevant biomarkers may provide insights into mechanisms underlying potential PA effects on cognition. Methods:We systematically reviewed randomized controlled trials (RCTs) that studied PA effects on biomarkers in MCI, AD, and dementia populations. We examined whether biological mechanisms were hypothesized to explain associations among PA, biomarkers, and cognitive functions.We used the PubMed database and searched for RCTs with PA until October 31, 2019. Results: Of 653 studies examining changes in biomarkers in PA trials, 18 studies met inclusion criteria for the present review. Some studies found favorable effects of PA on neurotrophic and inflammatory biomarkers. AD pathological markers were rarely investigated, with inconclusive results. Most studies were relatively small in sample size, of limited duration, and not all studies compared the changes in biomarkers between the control and experimental groups. Discussion: There is only limited use of potentially informative biomarkers in PA trials for MCI, AD, and dementia.Most studies did not examine the role of biomarkers to study associations between PAand cognitive functions in their analyses. Several potential biomarkers remain uninvestigated. Careful use of biomarkers may clarify mechanisms underlying PA effects on cognition. Our review serves as a useful resource for developing future PA RCTs aimed at improving cognitive functions in MCI, AD, and dementias.
KW - Alzheimer’s disease
KW - biomarkers related to dementia
KW - brain health
KW - dementia
KW - exercise
KW - mild cognitive impairment
KW - neurobiological biomarkers
KW - physical activity
KW - underlying mechanism
UR - http://www.scopus.com/inward/record.url?scp=85121219070&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121219070&partnerID=8YFLogxK
U2 - 10.1002/trc2.12109
DO - 10.1002/trc2.12109
M3 - Article
AN - SCOPUS:85121219070
SN - 2352-8737
VL - 6
JO - Alzheimer's and Dementia: Translational Research and Clinical Interventions
JF - Alzheimer's and Dementia: Translational Research and Clinical Interventions
M1 - e12109
ER -